PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: Financial statements 2012
CVR: 33242840
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS (CVR 33242840) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 2,188,044 and a net result of DKK 145,112. Equity in the 2012 report amounted to DKK 308,050. The solvency ratio was 42.6%.
- Gross Profit
- DKK 2,188,044
- Profit/Loss
- DKK 145,112
- Equity
- DKK 308,050
- Total Assets
- DKK 723,910
Official annual report
Keep an eye on PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Thomas Noel O´Leary. The board consists of Thomas Noel O´Leary (chair), John Sheahan and Simon Peter Hollywood. The company is owned by ICON CLINICAL (UK) LIMITED. The company has 49 employees (2026). In 2025, the company reported a gross profit of DKK 61,634,124 and a net result of DKK 3,053,580 compared with DKK 3,554,282 the year before. Equity in the 2025 report amounted to DKK 23,945,884.